No Data
No Data
Is Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Apeloa Pharmaceutical (000739.SZ): Hydrochloride jingangwulanium tablets have obtained approval for listing by the FDA in the USA.
Apeloa Pharmaceutical (000739.SZ) announced that its wholly-owned subsidiary, Zhejiang Jutai Pharmaceutical Co., Ltd., ...
Apeloa Pharmaceutical Teams Up With Startup to Produce Biosynthetic Products; Shares Up 7%
apeloa pharmaceutical (000739.SZ): Buyback completed, repurchased 0.93% of shares.
On September 27, Gelonhui announced that as of September 26, 2024, Apeloa Pharmaceutical (000739.SZ) disclosed that the company has repurchased a total of 10,880,000 shares of the company through a share buyback special securities account in a centralized bidding trading manner, accounting for 0.93% of the current total share capital of the company, with a highest fill price of 15 yuan/share, a lowest fill price of 12.64 yuan/share, and a total transaction amount of RMB 153,070,084 (excluding transaction costs), the funds for repurchasing shares are from the company's own funds. This buyback complies with relevant laws and regulations, and is in line with the company's share buyback program, this buyback.
Apeloa Pharmaceutical (000739.SZ) has signed a strategic cooperation agreement with Baikui Rui.
Gelonghui 26th September | Apeloa Pharmaceutical (000739.SZ) announced that the company has cooperated with Baikuirui (Shenzhen) Biological Technology Co., Ltd. (hereinafter referred to as "Baikuirui") in an open and cooperative manner based on the principles of honesty, equality, and win-win situation. By complementing each other's advantages in existing products, production capacity, and technology, the two parties have achieved strong cooperation. In order to strengthen cooperation and establish a future-oriented global strategy partnership, both parties are willing to become strategic partners and have recently signed a "Strategic Cooperation Agreement". Baikuirui has developed and produced through its protein precision design and Smart Evolution machine learning algorithm platform.
Apeloa Pharmaceutical (000739.SZ): Apeloa Hong Kong plans to invest 2.75 million US dollars to subscribe for 815,900 shares of Series D preferred stock of Jixing Company.
Gelonghui September 19th | Apeloa Pharmaceutical (000739.SZ) announced that recently, Apeloa Hong Kong Limited, a subsidiary of Apeloa Pharmaceutical Co., Ltd., has jointly signed a "
No Data
No Data